Jason Tardio serves as Executive at Ovid Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Jason Tardio has executed 2 insider transactions totaling $37.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 22, 2024 involved receiving (via award) 28,125 shares valued at $0.
Jason Tardio currently holds 28,125 shares of Ovid Therapeutics Inc. (OVID), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Tardio has been a net seller of OVID stock. They have purchased $0 and sold $37.3K worth of shares.
Jason Tardio's most recent insider trade was on Feb 22, 2024, when they sold 28,125 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.15 |
| Discretionary |